Search by Drug Name or NDC

    NDC 65086-0002-05 Omlonti 0.02 mg/mL Details

    Omlonti 0.02 mg/mL

    Omlonti is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Santen Incorporated. The primary component is OMIDENEPAG ISOPROPYL.

    Product Information

    NDC 65086-0002
    Product ID 65086-002_074cf154-7476-e203-e063-6294a90ab60e
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Omlonti
    Proprietary Name Suffix n/a
    Non-Proprietary Name omidenepag isopropyl
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION/ DROPS
    Route OPHTHALMIC
    Active Ingredient Strength 0.02
    Active Ingredient Units mg/mL
    Substance Name OMIDENEPAG ISOPROPYL
    Labeler Name Santen Incorporated
    Pharmaceutical Class Prostaglandin E2 Receptor Agonist [EPC], Prostaglandin E2 Receptor Agonists [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA215092
    Listing Certified Through 2024-12-31

    Package

    NDC 65086-0002-05 (65086000205)

    NDC Package Code 65086-002-05
    Billing NDC 65086000205
    Package 1 BOTTLE, PLASTIC in 1 CARTON (65086-002-05) / 2.5 mL in 1 BOTTLE, PLASTIC
    Marketing Start Date 2022-09-23
    NDC Exclude Flag N
    Pricing Information N/A
    << 65086-0002-01 65087-0001-01 >>

    Contents